FibroBiologics FBLG
NASDAQ FBLG
$1.76 +0.04 (+2.44%)
At close: Sep 9, 2026 · 4:00 PM EDT

FibroBiologics (FBLG) EPS (Diluted) (2023 - 2026)

Analysis

FibroBiologics (FBLG) EPS (Diluted) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn 1.79
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - -0.94
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn -0.11
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn 0.42
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn -1.22
6 Beam Therapeutics 3.06 Bn 3.06 Bn - -1.18
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn 0.05
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn -0.05
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn 0.04
10 FibroBiologics 12.05 Mn 12.05 Mn - -0.64
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.64
Mar 31, 2026 -1.34
Dec 31, 2025 -1.24
Sep 30, 2025 -2.31
Jun 30, 2025 -2.41
Mar 31, 2025 -2.71
Dec 31, 2024 -1.89
Sep 30, 2024 -0.30
Jun 30, 2024 0.55
Mar 31, 2024 -5.43
Dec 31, 2023 -6.88
Sep 30, 2023 -1.55
Jun 30, 2023 -1.53
Mar 31, 2023 -3.53